The Pepsinogen Releasing Effect of Helicobacter pylori Lipopolysaccharide

Helicobacter

Volumn 7, Issue , 2002, Pages 30-36

  Young, G O ^a   Brown, S ^a   Stemmet, N ^a   Lastovica, A J ^a   Marks, I N ^a   Modlin, I M ^b   Kidd, M ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLECYSTOKININ OCTAPEPTIDE; PEPSINOGEN; POLYMYXIN B;

ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEPHOSPHORYLATION; GUINEA PIG; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA;

ADULT; ANIMALS; DUODENAL ULCER; FEMALE; GASTRIC MUCOSA; GUINEA PIGS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIPOPOLYSACCHARIDES; MALE; PEPSINOGENS; VIRULENCE;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAVIA PORCELLUS; HELICOBACTER; HELICOBACTER PYLORI; SUS SCROFA;

EID: 0036126085     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2002.00053.x     Document Type: Article

References (40)

1. Malfertheiner P, Mégraud F, O'Morain C, et al. The European Helicobacter pylori Study Group. Current concepts in the management of H. pylori infection-The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
2. Bytzer P, Aalykke C, Rune S, et al. and the Danish Ulcer Study Group. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. Scand J Gastroenterol 2000;10:1023-32.
3. van der Wouden EJ, Thijs JC, van Zwet AA, Kleibeuker JH. Six-year follow-up after successful triple therapy for H. pylori infection in patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2001;13:1235-9.
4. Huang J-Q, Sridhar A, Hunt RH. Role of H. pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis. Lancet 2002;359:14-22.
5. Hawkey CJ, Tulassay Z, Szczepanski L et al. Randomised controlled trial of H. pylori eradication in patients on non-steroidal inflammatory drugs. HELP NSAIDS Study. Lancet 1998;352:1016-21.
6. Chan FKL, Sung JJY, Suen R, et al. Does eradication of H. pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomised study. Aliment Pharmacol Ther 1998;12:1201-5.
7. Chan FKL, To KF, Wu JCY, et al. Eradication of H. pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomised trial. Lancet 2002;359:9-13.
8. Chan FK, Sung JY, Chung SC, et al. Randomised trial of eradication of H. pylori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-9.
9. Chan FK, Chung Sc, Suen Bym Lee YT, et al. Preventing recurrent upper gastrointestinal bleeding in patients with H. pylori infection who are taking low-dose aspirin or naproxen. New Engl J Med 2001;344:967-73.
10. Peek RM, Chan FKL. Elimination of H. pylori or acid in high-risk users of aspirin or non-steroidal medications: Final answer? Gastroenterology 2002;122:238-40.
11. Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J, Richards ID, Dowell AC, Axon AT. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomised controlled trial. Leeds HELP Study Group. Lancet 2000;355:1665-9.
12. Froehlich F, Gonvers JJ, Wietlisbach V, et al. and the Eradication in Dyspepsia Study Group. H. pylori Eradication treatment does not benefit patients with non-ulcer dyspepsia. Am J Gastroenterol 2001;96:2329-36.
13. Bruley des Varannes S, Fléjou JF, Colin R, ZaYm M, Meuniers A, Bidaut-Mazel C. There are some benefits for eradication H. pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2001;15:1177-85.
14. Laine L, Schoenfeld P, Fennerty MB. Therapy for H. pylori in patients with non-ulcer dyspepsia. Ann Int Med 2001;134:361-9.
15. Moayyedi P, Soo S, Deeks J, et al. on behalf of the Dyspepsia Review Group. Systematic review and economic evaluation of H. pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000;321:659-64.
16. Moayyedi P, Deeks J, Forman D. H. pylori eradication therapy for non-ulcer dyspepsia. Ann Int Med 2002;136:555. Letter.
17. Soo S, Moayyedi P, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2002.
18. Sheu B-S, Yang H-B, Wang Y-L, Chuang C-H, Huang A-H, Wu J-J. Pre-treatment gastric history is helpful to predict the symptomatic response after H. pylori eradication in patients with non-ulcer dyspepsia. Dig Dis Sci 2001;46:2700-7.
19. Xia HH-X, Phung N, Altiparmak E, Berry A, Methson M, Talley N. Reduction of peptic ulcer disease and H. pylori infection but increase in reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci 2001;46:2716-23.
20. Fallone CA, Barkun AN, Gottke MU, et al. Association of Helicobacterpylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J Gastroenterol 2000;95:659-69.
21. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999;45:181-5.
22. Kim N, Lim SH, Lee KH. No protective role of H. pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci 2001;46:2724-32.
23. Öberg S, Peters JH, Nigro JJ, et al. H. pylori is not associated with the manifestations of gastroesophageal relfux disease. Arch Surg 1999;134:72-6.
24. Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-6.
25. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M. Helicobacter pylori and symptomatic relapse of gastrooesophageal reflux disease: A randomised controlled trial. Lancet 2001;357:1738-42.
26. Armstrong D, Pare P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group. Symptom relief in gastroesophageal reflux disease: A randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopynegative reflux disease. Am J Gastroenterol 2001; 96:2849-57.
27. Warburton-Timms VJ, Charlett A, Valori RM, Uff JS, Shepherd NA, Barr H, McNulty CA. The significance of cagA (+) Helicobacter pylori in reflux oesophagitis. Gut 2001;49:341-6.
28. Rokkas T, Ladas SD, Triantafyllou K, Liatsos C, Petridou E, Papatheodorou G, Karameris A, Raptis SA. The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori. Am J Med 2001;110:703-7.
29. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Toyota T, Shimosegawa T. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-4.
30. Richter JE. H pylori: The bug is not all bad. Gut 2001;49:319-20.
31. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324:012-9.
32. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, Hobbs FD. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ 2001;322:898-901.
33. Delaney BC, Innes MA, Deeks J, et al. Initial management strategies for dyspepsia (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2002.
34. Duggan AE, Elliott CA, Hawkey CJ, Logan RFA. Does initial management of patients with dyspepsia alter symptom response and patient satisfaction? Results from a randomised trial. Gastroenterology 1999;116:G0654.
35. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylori test-anderadicate versus prompt endoscopy for management of dyspeptic patients: A randomised trial. Lancet 2000;356:455-60.
36. Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB, Tham TC. A prospective randomised trial of a 'test and treat' policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-90.
37. McColl KEL, Murray LS, Gillen D, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. BMJ 2002;324:999-1007.
38. Delaney B, Moayyedi P, Deeks J, et al. The management of dyspepsia: A systematic review. Health Technol Assessment 2000;4:1-189.
39. Spiegel BMR, Vakil NB, Ofman JJ. Dyspepsia management in primary care: A reappraisal of competing strategies. Gastroenterology 2002;122:1270-85.
40. Talley NJ. Dyspepsia management in the millennium the death of test and treat? Gastroenterology 2002;122:1521-5.